• Pfizer average return on tangible equity for 2023 was 200.79, a 108.91% decline from 2022.
• Pfizer average return on tangible equity for 2022 was -2253.24, a 711.54% decline from 2021.
• Pfizer average return on tangible equity for 2021 was -277.65, a 511.97% increase from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.